Press release
Metastatic Colorectal Cancer Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Mirati Therapeutics, Merck, Pfizer, Isofol Medical, Alexion, Qilu, G1 Therapeutics, Zentalis Pharmaceuticals
"Metastatic Colorectal Cancer Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Metastatic Colorectal Cancer Therapeutics Market.
The report provides a detailed description of the Metastatic Colorectal Cancer drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Metastatic Colorectal Cancer Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/metastatic-colorectal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Metastatic Colorectal Cancer Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Metastatic Colorectal Cancer therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Metastatic Colorectal Cancer treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Metastatic Colorectal Cancer drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Metastatic Colorectal Cancer treatment market.
Learn More about the Clinical and Commercial Development Activities in the Metastatic Colorectal Cancer Therapeutics Domain:
https://www.delveinsight.com/report-store/metastatic-colorectal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Metastatic Colorectal Cancer Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Route of Administration
Metastatic colorectal cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Metastatic Colorectal Cancer Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/metastatic-colorectal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Metastatic Colorectal Cancer Therapeutics Analysis
There are approx. 130+ key companies developing therapies for Metastatic colorectal cancer. Currently, Mirati Therapeutics is leading the therapeutics market with its Metastatic colorectal cancer drug candidates in the most advanced stage of clinical development.
Metastatic Colorectal Cancer Companies in the Therapeutics Market Include:
Aadi Bioscience, Inc., Arcus Biosciences, Inc., Boehringer Ingelheim, Cardiff Oncology, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Elevar Therapeutics, Genentech, Genor Biopharma Co., Ltd., Henlix Biotech, Immunovative Therapies, Ltd., Isofol Medical, Menarini Group, Merck Serono, Mirati Therapeutics, Novartis, Qilu Pharmaceutical Co., Ltd., Roche, Scandion Oncology A/S, SFJ Pharmaceuticals, Shanghai Henlius Biotech, Shanghai Zhangjiang Biotechnology Limited Company, Sumitomo Pharma Co., Ltd., Suzhou Suncadia Biopharmaceuticals Co., Ltd., Symphogen A/S, Treos Bio, and many others.
Emerging and Marketed Metastatic Colorectal Cancer Therapies Covered in the Report Include:
• Adagrasib (MRTX849) + cetuximab: Mirati Therapeutics + Merck
• Braftovi (encorafenib) + Erbitux (cetuximab) ± Mektovi (binimetinib): Array BioPharma/ Pfizer + Pfizer
• Corsela (trilaciclib): G1 Therapeutics
• Elunate (fruquintinib/HMPL-013): Hutchison Medipharma
• Jemperli (dostarlimab): GlaxoSmithKline (GSK)
• Keytruda (pembrolizumab) injection: Merck
• MK-4280A (favezelimab and pembrolizumab): Merck
• Modufolin (arfolitixorin): Isofol Medical
• QL-1203: Qilu Pharmaceutical
• Stivarga (Regorafenib): Alexion Pharmaceuticals
• ZN-c3: Zentalis Pharmaceuticals
And Many More
Get an in-depth Assessment of the Emerging Therapies and Metastatic Colorectal Cancer Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/metastatic-colorectal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Metastatic Colorectal Cancer Current Treatment Patterns
4. Metastatic Colorectal Cancer - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Metastatic Colorectal Cancer Late-Stage Products (Phase-III)
7. Metastatic Colorectal Cancer Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Metastatic Colorectal Cancer Discontinued Products
13. Metastatic Colorectal Cancer Product Profiles
14. Metastatic Colorectal Cancer Companies
15. Metastatic Colorectal Cancer Drugs
16. Dormant and Discontinued Products
17. Metastatic Colorectal Cancer Unmet Needs
18. Metastatic Colorectal Cancer Future Perspectives
19. Metastatic Colorectal Cancer Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/metastatic-colorectal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight -
Messenger RNA (mRNA)-based Vaccines and Therapeutics Market
https://www.delveinsight.com/report-store/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market
Narcolepsy Market
https://www.delveinsight.com/report-store/narcolepsy-market
Osteoporosis Market
https://www.delveinsight.com/report-store/osteoporosis-market
Carcinoid Tumor Syndrome Market
https://www.delveinsight.com/report-store/carcinoid-tumor-syndrome-market
Migraine Market
https://www.delveinsight.com/report-store/migraine-market
Emphysema Market
https://www.delveinsight.com/report-store/emphysema-market
Substance use disorder Market
https://www.delveinsight.com/report-store/substance-use-disorder-market
Tumor Ablation Market
https://www.delveinsight.com/report-store/tumor-ablation-market
Campylobacter Infections Market
https://www.delveinsight.com/report-store/campylobacter-infections-market
mRNA Vaccine and Therapeutics Market
https://www.delveinsight.com/report-store/mrna-vaccine-and-therapeutics-market
Breast Pumps Market
https://www.delveinsight.com/report-store/breast-pumps-market
Negative Pressure Wound Therapy Systems Market
https://www.delveinsight.com/report-store/negative-pressure-wound-therapy-systems-market
Obsessive-Compulsive Disorder Market
https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-market
Diabetic Eye Disease Market
https://www.delveinsight.com/report-store/diabetic-eye-disease-market
Seborrhoeic Dermatitis Market
https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market
Hernia Repair Devices Market
https://www.delveinsight.com/report-store/hernia-repair-devices-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metastatic Colorectal Cancer Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Mirati Therapeutics, Merck, Pfizer, Isofol Medical, Alexion, Qilu, G1 Therapeutics, Zentalis Pharmaceuticals here
News-ID: 3134183 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Metastatic
Key Trends Reshaping the Metastatic Bone Disease Market: Advancements in Targete …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Metastatic Bone Disease Market Size Growth Forecast: What to Expect by 2025?
The market size for metastatic bone disease has seen a quick expansion in the past few years. This market will increase from a value of $17.14 billion in 2024 to $18.88 billion in 2025, with a compound…
Emerging Trends Influencing The Growth Of The Metastatic Urothelial Carcinoma Ma …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Metastatic Urothelial Carcinoma Market Size Expected to Be by 2034?
The market size for metastatic urothelial carcinoma has seen exponential growth recently. The market will expand from a worth of $1.18 billion in 2024 to $1.42 billion in 2025, with a compound annual growth rate (CAGR) of 20.2%.…
Key Influencer in the Metastatic Cancer Drugs Market 2025: Surging Prevalence Of …
How Are the key drivers contributing to the expansion of the metastatic cancer drugs market?
The escalation in the incidence of metastatic cancers will be a driving force for the expansion of the metastatic cancer drugs market. Metastatic cancer is a late-stage cancer that spreads across the body. As the number of metastatic cancer cases escalates, so does the creation of innovative drugs to treat various kinds of metastatic cancers. The…
Prominent Metastatic Breast Cancer Treatment Market Trend for 2025: Advancements …
Which drivers are expected to have the greatest impact on the over the metastatic breast cancer treatment market's growth?
The increasing occurrence of breast cancer is anticipated to boost the progression of the metastatic breast cancer treatment market. Breast cancer is a form of the disease that originates in the breast cells and is caused by abnormal cell growth in the breast, leading to the formation of a tumor. This alteration…
Major Force in the Metastatic Bone Disease Market 2025: Impact Of Bone Cancer Pr …
How Will the Metastatic Bone Disease Market Grow, and What Is the Projected Market Size?
The market size for metastatic bone disease has seen considerable growth in recent years. There is an expected increase from $17.14 billion in 2024 to $18.88 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%. The substantial growth during the historical period can be credited to factors like rising aging population, heightened cancer…
Combination Therapy Strategies for Metastatic Cancer
Metastatic cancer, where cancer cells spread from the primary tumor to distant organs, presents significant treatment challenges. Combination therapy strategies have emerged as a powerful approach to enhance treatment efficacy, overcome resistance, and improve patient outcomes in metastatic cancer.
Download Report:
https://www.kuickresearch.com/report-cancer-antibody-combinations-therapy-cancer-antibody-combination-monoclonal-antibodies-combination-drug-conjugate-antibodies-combination
One of the primary goals of combination therapy in metastatic cancer is to target both the primary tumor and metastatic sites. This comprehensive approach can improve overall disease control…
